Mariani-Pedroso S R, Bizeto L, Antunes E, Zatz R, de Nucci G
Department of Pharmacology, Faculty of Medical Sciences, UNICAMP, Campinas (SP), Brazil.
Prostaglandins Leukot Essent Fatty Acids. 1995 Jun;52(6):399-402. doi: 10.1016/0952-3278(95)90068-3.
The ability of prostaglandin E1 (PGE1) and nitric oxide (NO) donor compounds such as sodium nitroprusside (SNP), glyceryl trinitrate (GTN), and 3-morpholino-sydnonimine (SIN-1) to modulate the histamine- and bradykinin-induced increase in microvascular permeability have been investigated in rabbit skin. The effect of the NO synthesis inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) on the plasma exudation induced by histamine and bradykinin was also studied. Local edema formation was evaluated using [125I]human serum albumin. New Zealand white rabbits received an intravenous injection of [125I]human albumin followed immediately by the intradermal injection of edematogenic agents into the shaved dorsolateral skin. PGE1 (0.1 nmol/site) significantly potentiated both histamine- and bradykinin-induced edema. In contrast, SNP (0.4-400 nmol/site), SIN-1 (0.4-400 nmol/site), and GTN (0.4-40 nmol/site) did not affect the edematogenic response induced by either histamine or bradykinin. GTN (0.4-40 nmol/site) also had no effect on the increase in plasma exudation induced by histamine and bradykinin in the presence of PGE1. L-NAME (50-400 nmol/site, but not its enantiomer D-NAME, dose-dependently reduced the edema formation induced by a combination of either histamine or bradykinin with PGE1. This inhibition was significantly reversed by SNP (4-400 nmol/site) and by high doses (2.5 mumol/site) of L-arginine (but not by D-arginine). Our results thus demonstrate that PGE1, but not nitrovasodilators, can actually potentiate histamine- and bradykinin-induced edema in rabbit skin.(ABSTRACT TRUNCATED AT 250 WORDS)
在兔皮肤中研究了前列腺素E1(PGE1)和一氧化氮(NO)供体化合物(如硝普钠(SNP)、硝酸甘油(GTN)和3-吗啉代西多胺(SIN-1))调节组胺和缓激肽诱导的微血管通透性增加的能力。还研究了NO合成抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME)对组胺和缓激肽诱导的血浆渗出的影响。使用[125I]人血清白蛋白评估局部水肿形成。新西兰白兔静脉注射[125I]人白蛋白,随后立即将致水肿剂皮内注射到剃毛的背外侧皮肤中。PGE1(0.1 nmol/部位)显著增强组胺和缓激肽诱导的水肿。相比之下,SNP(0.4 - 400 nmol/部位)、SIN-1(0.4 - 400 nmol/部位)和GTN(0.4 - 40 nmol/部位)对组胺或缓激肽诱导的致水肿反应均无影响。在存在PGE1的情况下,GTN(0.4 - 40 nmol/部位)对组胺和缓激肽诱导的血浆渗出增加也无影响。L-NAME(50 - 400 nmol/部位,但不是其对映体D-NAME)剂量依赖性地减少组胺或缓激肽与PGE1联合诱导的水肿形成。SNP(4 - 400 nmol/部位)和高剂量(2.5 μmol/部位)的L-精氨酸(但不是D-精氨酸)可显著逆转这种抑制作用。因此,我们的结果表明,PGE1而非硝基血管扩张剂实际上可增强兔皮肤中组胺和缓激肽诱导的水肿。(摘要截短至250字)